We are live on ! Find out more
TWST icon

Twist Bioscience
TWST

222 hedge funds and large institutions have $6.06B invested in Twist Bioscience in 2020 Q4 according to their latest regulatory filings, with 60 funds opening new positions, 68 increasing their positions, 70 reducing their positions, and 30 closing their positions.

New
Increased
Maintained
Reduced
Closed

102% more capital invested

Capital invested by funds: $3.01B → $6.06B (+$3.05B)

100% more first-time investments, than exits

New positions opened: 60 | Existing positions closed: 30

80% more funds holding in top 10

Funds holding in top 10: 5 → 9 (+4)

15% more funds holding

Funds holding: 193 → 222 (+29)

0.74% more ownership

Funds ownership: 88.9% → 89.64% (+0.74%)

3% less repeat investments, than reductions

Existing positions increased: 68 | Existing positions reduced: 70

15% less call options, than puts

Call options by funds: $25.2M | Put options by funds: $29.6M

Holders
222
Holders Change
+29
Holders Change %
+15.03%
% of All Funds
3.93%
Holding in Top 10
9
Holding in Top 10 Change
+4
Holding in Top 10 Change %
+80%
% of All Funds
0.16%
New
60
Increased
68
Reduced
70
Closed
30
Calls
$25.2M
Puts
$29.6M
Net Calls
-$4.4M
Net Calls Change
-$7.21M

Top Buyers

1
AIM
ARK Investment Management
Florida
+$301M
2
Capital World Investors
Capital World Investors
California
+$149M
3
Vanguard Group
Vanguard Group
Pennsylvania
+$126M
4
CS
Credit Suisse
Switzerland
+$88.8M
5
William Blair Investment Management
William Blair Investment Management
Illinois
+$50.4M

Top Sellers

1
JP Morgan Chase
JP Morgan Chase
New York
-$83.2M
2
Wellington Management Group
Wellington Management Group
Massachusetts
-$72.1M
3
State Street
State Street
Massachusetts
-$37.2M
4
Fidelity Investments
Fidelity Investments
Massachusetts
-$35.2M
5
CAM
Cormorant Asset Management
Massachusetts
-$30.5M
Name Holding Trade Value Shares
Change 		Change in
Stake
AIM
1
ARK Investment Management
Florida
$830M +$301M +2,716,493 +86%
Vanguard Group
2
Vanguard Group
Pennsylvania
$498M +$126M +1,140,123 +48%
BlackRock
3
BlackRock
New York
$494M +$41.1M +370,176 +12%
Capital World Investors
4
Capital World Investors
California
$417M +$149M +1,339,320 +83%
Invesco
5
Invesco
Georgia
$323M +$39.1M +352,029 +18%
Sumitomo Mitsui Trust Group
6
Sumitomo Mitsui Trust Group
Japan
$261M +$26M +234,339 +14%
NAMA
7
Nikko Asset Management Americas
New York
$260M +$24.8M +223,928 +14%
JP Morgan Chase
8
JP Morgan Chase
New York
$256M -$83.2M -750,136 -29%
TCM
9
Tao Capital Management
California
$156M -$14.2M -127,744 -10%
Fidelity Investments
10
Fidelity Investments
Massachusetts
$156M -$35.2M -317,140 -22%
State Street
11
State Street
Massachusetts
$156M -$37.2M -334,923 -23%
CC
12
Casdin Capital
New York
$141M – – –
T. Rowe Price Associates
13
T. Rowe Price Associates
Maryland
$137M +$35.2M +317,301 +49%
Bank of New York Mellon
14
Bank of New York Mellon
New York
$133M -$9.84M -88,667 -9%
AllianceBernstein
15
AllianceBernstein
Tennessee
$128M -$29.5M -265,894 -23%
CS
16
Credit Suisse
Switzerland
$120M +$88.8M +800,661 +1,744%
William Blair Investment Management
17
William Blair Investment Management
Illinois
$106M +$50.4M +454,483 +153%
Goldman Sachs
18
Goldman Sachs
New York
$91.3M +$23.2M +208,803 +48%
Wells Fargo
19
Wells Fargo
California
$89.8M -$11.6M -104,151 -14%
MWNA
20
Marshall Wace North America
New York
$86M +$34.5M +311,033 +105%
Geode Capital Management
21
Geode Capital Management
Massachusetts
$83.1M +$3.95M +35,591 +6%
Victory Capital Management
22
Victory Capital Management
Texas
$78.9M +$28.3K +255 +0%
Marshall Wace
23
Marshall Wace
United Kingdom
$74.5M -$6.59M -59,372 -10%
D.E. Shaw & Co
24
D.E. Shaw & Co
New York
$73.8M -$14.9M -133,982 -20%
Lord, Abbett & Co
25
Lord, Abbett & Co
New Jersey
$62.3M -$12.6M -113,200 -20%
1
2 3 4 5

TWST Hedge Fund Activity: Q4 2020 in Review

222 of the 5,651 institutional investors tracked by Wall St. Rank reported a position in Twist Bioscience (TWST) for Q4 2020, worth a combined $6.06B — up 102% from $3.01B a quarter earlier.

Buyers outnumbered sellers: 60 funds opened new TWST positions and 30 closed out — a net gain of 30 holders — while 68 added to existing stakes and 70 trimmed.

The largest buyer was ARK Investment Management, adding an estimated $301M. The largest seller was JP Morgan Chase, cutting an estimated $83.2M.

  • 222 institutional investors held Twist Bioscience (TWST) as of Q4 2020, up from 193 in Q3 2020.
  • Funds reported $6.06B of Twist Bioscience stock for Q4 2020, up 102% quarter-over-quarter.
  • 60 funds opened new Twist Bioscience positions in Q4 2020 and 30 closed out, a net change of +30 holders.
  • The largest Twist Bioscience buyer in Q4 2020 was ARK Investment Management, an estimated $301M added.
  • The largest Twist Bioscience seller in Q4 2020 was JP Morgan Chase, an estimated $83.2M sold.

Based on aggregated 13F filings for Q4 2020.